Concord Medical Announces a Topping Out Ceremony of Guangzhou Concord Cancer Center
BEIJING, Dec. 19, 2018 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, announced a topping out ceremony of Guangzhou Concord Cancer Center (the "Center") has been held at the construction site of the project.
The Center has a construction area of 100,000 square meters, with 400 beds planned for two phases. The design of the Center is jointly completed by HKS, an internationally renowned American architectural design firm with a rich experience in hospital design, and Shanghai Architectural Design and Research Institute, which has proton center design experience in China. The construction started in February 2017 and the hospital is expected to be in full operation in early 2020.
As one of the core projects of life and health in Sino-Singapore Guangzhou Knowledge City, the Center will be positioned as a "five in one" medical institution, integrating the clinical diagnosis and treatment, prevention, scientific research, training and remote consultation. The hospital will have complete cancer comprehensive diagnosis, treatment and adjuvant treatment department and will be equipped with Varian ProBeam multi-room proton therapy system, multiple linear accelerators, Da Vinci surgical robots and other high-end medical equipment. The construction of the Center in Guangzhou allows the Chinese cancer patients to enjoy the advanced cancer diagnosis and treatment technology without the need to going abroad.
About Concord Medical
Concord Medical Services Holdings Limited is a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China. As of June 30, 2018, the Company operated a network of 30 centers with 21 hospital partners that spanned 21 cities and 14 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, the Company provides radiotherapy and diagnostic imaging equipment and manages the daily operations of these centers, which are located on the premises of its hospital partners. The Company also provides ongoing training to doctors and other medical professionals in its network of centers to ensure a high level of clinical care for patients. For more information, please see http://ir.ccm.cn.
SOURCE Concord Medical Services Holdings Limited
Upcoming Life Sciences Events
- September 2019
- Dusseldorf: 5th Annual Pre-Filled Syringes & Injectables Summit
- Munich: The Biotech & Pharma Summit: Drug Delivery & Formulation
- Brussels: The Pharma Forecasting Course